Late cerebral graft versus host reaction in a bone marrow transplanted girl with Hurler (MPS I) disease

Neuropediatrics

Volumn 39, Issue 5, 2008, Pages 249-251

  Kyllerman, M ^a   Himmelmann, K ^a   Fasth, A ^a   Nordborg, Claes ^b   Mansson J E ^b  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Graft versus host reaction; Hurler disease; Neurochemistry; Neuropathology

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIGOXIN; DIURETIC AGENT; MEROPENEM; PREDNISOLONE; THYMOCYTE ANTIBODY; VANCOMYCIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BRAIN DISEASE; BRAIN HEMORRHAGE; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ENDOSCOPY; EPILEPSY; FEMALE; GRAFT VERSUS HOST REACTION; HEART FAILURE; HUMAN; HUMAN CELL; HURLER SYNDROME; IMMUNOHISTOCHEMISTRY; INFECTION; PRIORITY JOURNAL; SEPTICEMIA; SURGICAL DRAINAGE;

BONE MARROW TRANSPLANTATION; BRAIN; BRAIN DISEASES; CEREBRAL HEMORRHAGE; CEREBROSPINAL FLUID; CHILD; DEMYELINATING DISEASES; FEMALE; FOLLOW-UP STUDIES; GALACTOSYLCERAMIDES; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MICROSCOPY, ELECTRON; MUCOPOLYSACCHARIDOSIS I; MYELIN SHEATH; SULFOGLYCOSPHINGOLIPIDS; VENTRICULOPERITONEAL SHUNT;

EID: 63249102874     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1112118     Document Type: Article

References (9)

1. Baxter MA, Wynn RF, Schyma F et al. Marrow stromal cells from patients affected by MPS I differentially support haematopoietic progenitor cell development. J Inher Metab Dis 2005; 28: 1045-1053
2. Kakkis ED. Enzyme replacement therapy in mucopolysaccharidosis I. New Engl J Med 2001; 344: 182-188
3. Kamble RT, Chang C-C, Sanchez S et al. Central nervous system graft-versus-host disease: report of two cases and literature review. Bone Marrow Transplant 2007; 39: 49-52
4. Krivit W, Peters C, Shapiro EG. Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher type disease type III. Curr Opin Neurol 1999; 12: 167-176
5. Marosi C, Budka H, Grimm G et al. Fatal encephalitis in a patient with chronic graft-versus-host disease. Bone Marrow Transplant 1990; 6: 53-57
6. Padovan CS, Gerbitz A, Sostak P et al. Cerebral involvement in graft-versus-host disease after bone marrow transplantation. Neurology 2001; 56: 1106-1108
7. Peters C, Balthazor M, Shapiro EG et al. Outcome of untreated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 1996; 87: 4894-4902
8. Takahashi Y, Sukegawa K, Aoki M et al. Evaluation of accumulated mucopolysaccharides in the brain of patients with mucopolysaccharidoses by (1)H-magnetic resonance spectroscopy before and after bone marrow transplantation. Pediatr Res 2001; 49: 349-355
9. Wraith JE. The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis 1. Expert Opin Pharmacother 2005; 6: 489-506